| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.enterohealthcare.com | |
| Market Cap | 5,020.05 Cr. | |
| Enterprise Value(EV) | 5,287.52 Cr. | 2023-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -2.66 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 65.05 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 359.88 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 3.21 | Calculated using Price: 1,154.20 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 4.35 Cr. | 43,493,767 Shares |
| FaceValue | 10 | |
| About Entero Healthcare Solutions Ltd. | ||
| Entero Healthcare Solutions is one of India's largest and fastest growing healthcare products distribution platforms. The company offers both demand generation and demand fulfilment solutions to healthcare product manufacturers. | ||
| 1 Day |
|
-1.53% |
| 1 Week |
|
+3.48% |
| 1 Month |
|
+16.16% |
| 3 Month |
|
|
| 6 Month |
|
|
| 1 Year |
|
|
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 3 years | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0 | 0 | 0 | |
| Return on Capital Employed (%) | 1.47 | 1.24 | 4.99 | |
| Return on Assets (%) | -1.84 | -3.01 | -0.91 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Shh. Funds | 485 | 561 | 595 | |
| Non Curr. Liab. | 57 | 100 | 85 | |
| Curr. Liab. | 289 | 462 | 624 | |
| Minority Int. | 2 | 2 | 3 | |
| Equity & Liab. | 833 | 1,125 | 1,307 | |
| Non Curr. Assets | 201 | 274 | 284 | |
| Curr. Assets | 633 | 851 | 1,023 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 833 | 1,125 | 1,307 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 1,780 | 2,522 | 3,300 | |
| Other Income | 4 | 4 | 6 | |
| Total Income | 1,784 | 2,527 | 3,306 | |
| Total Expenditure | -1,758 | -2,498 | -3,236 | |
| PBIDT | 25 | 29 | 70 | |
| Interest | -20 | -29 | -49 | |
| Depreciation | -16 | -20 | -24 | |
| Taxation | -5 | -10 | -7 | |
| Exceptional Items | ||||
| PAT | -15 | -29 | -11 | |
| Minority Interest | 0 | 0 | 0 | |
| Share Associate | ||||
| Other Related Items | ||||
| Consolidated Net Profit | -16 | -30 | -12 | |
| Adjusted EPS | -1,554 | -78 | -28 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -69 | -35 | -45 | |
| Cash Fr. Inv. | -31 | -162 | -49 | |
| Cash Fr. Finan. | 89 | 211 | 73 | |
| Net Change | -11 | 14 | -21 | |
| Cash & Cash Eqvt | 32 | 47 | 25 |
|
Wed, 24 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet |
|
Fri, 12 Apr 2024
Disclosure under SEBI Takeover Regulations Prabhat Agrawal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
Wed, 10 Apr 2024
Disclosure under SEBI Takeover Regulations OrbiMed Asia III Mauritius Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| Fri, 26 Apr 2024 |
Closing Below Previous Low
|
Close Within 52 Week High Zone
|
Closing Below Previous Low for 2 Days
|
Making Lower Lows for 2 Days
|
High Increase in 1 Month
|
